\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\ \(16\)\
\-\ surgery\\ and\\ radiation\\ therapy\ \(3\)\
\-\ \\â\\€\\¢\\ ct\\-\\-high\\ density\\ mass\\ lesion\\,\\ right\\ temporal\\ and\\ occipital\\ lobes\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\-\\-hemorrhagic\\ lesion\\,\\ with\\ irregular\\ enhancement\\ and\\ associated\\ vasogenic\\ edema\ \(0\)\
\-\ anaplastic\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ glioma\ \(2\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ ruptured\\ avm\ \(0\)\
\-\ 59\\ year\\ old\\ woman\\,\\ previously\\ healthy\\,\\ brought\\ to\\ outside\\ er\\ unresponsive\\.\\ \\ outside\\ ct\\ scan\\ was\\ abnormal\\.\ \(0\)\
\-\ brain\\ hemorrhage\\ was\\ diagnosed\\ on\\ outside\\ ct\\ scan\\.\\ \\ oligodendroglioma\\,\\ glioblastoma\\,\\ and\\ pituitary\\ macroadenoma\\ are\\ well\\-known\\ for\\ spontaneous\\ non\\-traumatic\\ hemorrhage\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ outside\\:\\ 0\\.12650858142747923\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.11785543374579244\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.0923569246057587\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0921773147997581\ \(0\)\
\-\ well\\-known\\:\\ 0\\.0847774177827341\ \(0\)\
\-\ non\\-traumatic\\:\\ 0\\.06970760783612158\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.06692368433355378\ \(0\)\
\-\ macroadenoma\\:\\ 0\\.06632311286610061\ \(0\)\
\-\ unresponsive\\:\\ 0\\.0653814339522943\ \(0\)\
\-\ anaplastic\\:\\ 0\\.06331213199389826\ \(0\)\
\-\ scan\\:\\ 0\\.05628874024548185\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.055348759526978666\ \(0\)\
\-\ brought\\:\\ 0\\.05460154298906895\ \(0\)\
\-\ vasogenic\\:\\ 0\\.0544219256698832\ \(0\)\
\-\ 59\\:\\ 0\\.05407071433871049\ \(0\)\
\-\ ruptured\\:\\ 0\\.052306712605876195\ \(0\)\
\-\ contributory\\:\\ 0\\.05172562136670471\ \(0\)\
\-\ pituitary\\:\\ 0\\.05038728153897932\ \(0\)\
\-\ avm\\:\\ 0\\.047889250536508804\ \(0\)\
\-\ occipital\\:\\ 0\\.046908290431343494\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.046908290431343494\ \(0\)\
\-\ spontaneous\\:\\ 0\\.046908290431343494\ \(0\)\
\-\ glioma\\:\\ 0\\.04532557404360695\ \(0\)\
\-\ healthy\\:\\ 0\\.04532557404360695\ \(0\)\
\-\ lobes\\:\\ 0\\.044301910784905425\ \(0\)\
\-\ previously\\:\\ 0\\.04223260882650938\ \(0\)\
\-\ ct\\:\\ 0\\.04218718776677798\ \(0\)\
\-\ non\\:\\ 0\\.04155664347327659\ \(0\)\
\-\ lesion\\:\\ 0\\.040954240611775404\ \(0\)\
\-\ temporal\\:\\ 0\\.040257539736636906\ \(0\)\
\-\ irregular\\:\\ 0\\.04009819591183976\ \(0\)\
\-\ er\\:\\ 0\\.038566872434681904\ \(0\)\
\-\ diagnosed\\:\\ 0\\.03696700184464712\ \(0\)\
\-\ density\\:\\ 0\\.033078015963058344\ \(0\)\
\-\ radiation\\:\\ 0\\.032991191171321606\ \(0\)\
\-\ brain\\:\\ 0\\.030251194391797197\ \(0\)\
\-\ abnormal\\:\\ 0\\.028671673415469546\ \(0\)\
\-\ edema\\:\\ 0\\.0284343939933093\ \(0\)\
\-\ high\\:\\ 0\\.027512306600903712\ \(0\)\
\-\ enhancement\\:\\ 0\\.02694692666027101\ \(0\)\
\-\ therapy\\:\\ 0\\.026878127014595448\ \(0\)\
\-\ metastatic\\:\\ 0\\.025307169454306944\ \(0\)\
\-\ surgery\\:\\ 0\\.024411753698356176\ \(0\)\
\-\ associated\\:\\ 0\\.02372308896362002\ \(0\)\
\-\ was\\:\\ 0\\.023253588757969103\ \(0\)\
\-\ woman\\:\\ 0\\.023222387617516545\ \(0\)\
\-\ mri\\:\\ 0\\.02309736299899553\ \(0\)\
\-\ \\,\\:\\ 0\\.019108945801220287\ \(0\)\
\-\ disease\\:\\ 0\\.016432206367243577\ \(0\)\
\-\ mass\\:\\ 0\\.013981894199383112\ \(0\)\
\-\ are\\:\\ 0\\.013704398500348255\ \(0\)\
\-\ year\\:\\ 0\\.011248297285563702\ \(0\)\
\-\ right\\:\\ 0\\.010607431871887256\ \(0\)\
\-\ old\\:\\ 0\\.010293348198379466\ \(0\)\
\-\ for\\:\\ 0\\.008577742925208413\ \(0\)\
\-\ on\\:\\ 0\\.008516364851357977\ \(0\)\
\-\ and\\:\\ 0\\.008471012034457338\ \(0\)\
\-\ to\\:\\ 0\\.005024330687564544\ \(0\)\
\-\ \\.\\:\\ 0\\.0016705664045810011\ \(0\)\
\-\ with\\:\\ 0\\.001376519718704585\ \(0\)\
